Robert W. Hallowell

2.2k total citations
36 papers, 756 citations indexed

About

Robert W. Hallowell is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Rheumatology. According to data from OpenAlex, Robert W. Hallowell has authored 36 papers receiving a total of 756 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pulmonary and Respiratory Medicine, 11 papers in Epidemiology and 9 papers in Rheumatology. Recurrent topics in Robert W. Hallowell's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (23 papers), Inflammatory Myopathies and Dermatomyositis (9 papers) and Eosinophilic Disorders and Syndromes (7 papers). Robert W. Hallowell is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (23 papers), Inflammatory Myopathies and Dermatomyositis (9 papers) and Eosinophilic Disorders and Syndromes (7 papers). Robert W. Hallowell collaborates with scholars based in United States, Japan and China. Robert W. Hallowell's co-authors include Sonye K. Danoff, Maureen R. Horton, Dana P. Ascherman, Jonathan D. Powell, Samuel L. Collins, Yee Chan‐Li, Julie J. Paik, Wayne Mitzner, Katharine E. Black and Samuel L. Collins and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Robert W. Hallowell

33 papers receiving 748 citations

Peers

Robert W. Hallowell

PRM

EPIDE

RHEUM

IMMUN

PHYSI

Susan Mathai United States

Chang Keun Lee South Korea

Angelo De Lauretis Italy

D. Adoué France

Mesias Pedroza United States

Louis J. Vuga United States

Alice Ballerie France

Takahiko Sugihara Japan

Netta Sion‐Vardy Israel

Elena Tagliabue Italy

Susan Mathai United States

Robert W. Hallowell

684 ×1.6

PRM

119 ×0.5

EPIDE

118 ×0.8

RHEUM

182 ×1.4

IMMUN

183 ×1.5

PHYSI

Citations per year, relative to Robert W. Hallowell Robert W. Hallowell (= 1×) peers Susan Mathai

Countries citing papers authored by Robert W. Hallowell

Since Specialization

Citations

This map shows the geographic impact of Robert W. Hallowell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert W. Hallowell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert W. Hallowell more than expected).

Fields of papers citing papers by Robert W. Hallowell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert W. Hallowell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert W. Hallowell. The network helps show where Robert W. Hallowell may publish in the future.

Co-authorship network of co-authors of Robert W. Hallowell

This figure shows the co-authorship network connecting the top 25 collaborators of Robert W. Hallowell. A scholar is included among the top collaborators of Robert W. Hallowell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert W. Hallowell. Robert W. Hallowell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Imai, Ryosuke, Sydney B. Montesi, Anjali Singh, et al.. (2025). Association of Anti-Ro52 Seropositive Interstitial Lung Disease With a Higher Risk of Disease Progression and Mortality. CHEST Journal. 168(4). 954–966. 3 indexed citations

Nandy, Sreyankar, Satomi Yamamoto, Jaeyul Lee, et al.. (2024). Microscopic Small Airway Abnormalities Identified in Early Idiopathic Pulmonary Fibrosis In Vivo Using Endobronchial Optical Coherence Tomography. American Journal of Respiratory and Critical Care Medicine. 210(4). 473–483. 7 indexed citations

Solomon, Joshua J., et al.. (2024). A digital therapy targeting anxiety in pulmonary fibrosis: A decentralized randomized controlled trial. Respirology. 30(3). 253–261. 2 indexed citations

Murphy, Mark C., Sydney B. Montesi, Lida P. Hariri, et al.. (2022). Diagnosis and Treatment of Lung Cancer in the Setting of Interstitial Lung Disease. Radiologic Clinics of North America. 60(6). 993–1002. 9 indexed citations

Ziehr, David R., et al.. (2022). Pulmonary amyloidosis as the presenting finding in a patient with multiple myeloma. Respiratory Medicine Case Reports. 37. 101626–101626.

Rubin, Jonah, Katharine E. Black, Robert W. Hallowell, et al.. (2021). Veno-Venous Extracorporeal Membrane Oxygenation for Myositis-Associated Rapidly Progressive Interstitial Lung Disease. CHEST Journal. 160(6). 2163–2167. 8 indexed citations

VanderLaan, Paul A., et al.. (2021). Pulmonary histopathology of interstitial lung disease associated with antisynthetase antibodies. Respiratory Medicine. 191. 106697–106697. 9 indexed citations

Li, Wenyuan, Gary M. Hunninghake, George R. Washko, et al.. (2020). Vascular Pruning on CT and Interstitial Lung Abnormalities in the Framingham Heart Study. CHEST Journal. 159(2). 663–672. 13 indexed citations

Rice, Mary B., Wenyuan Li, Joel Schwartz, et al.. (2019). Ambient air pollution exposure and risk and progression of interstitial lung abnormalities: the Framingham Heart Study. Thorax. 74(11). 1063–1069. 48 indexed citations

10.

Huapaya, J.A., Robert W. Hallowell, Leann Silhan, et al.. (2019). Long-term treatment with human immunoglobulin for antisynthetase syndrome-associated interstitial lung disease. Respiratory Medicine. 154. 6–11. 34 indexed citations

11.

Petri, Camille R., Rushad Patell, Felipe Batalini, Deepa Rangachari, & Robert W. Hallowell. (2019). Severe pulmonary toxicity from immune checkpoint inhibitor treated successfully with intravenous immunoglobulin: Case report and review of the literature. Respiratory Medicine Case Reports. 27. 100834–100834. 30 indexed citations

12.

Richeldi, Luca, Francesco Varone, Miguel Bergna, et al.. (2018). Pharmacological management of progressive-fibrosing interstitial lung diseases: a review of the current evidence. European Respiratory Review. 27(150). 180074–180074. 67 indexed citations

13.

Shea, Meghan, et al.. (2018). Radiologic and autopsy findings in a case of fatal immune checkpoint inhibitor-associated pneumonitis. Cancer Treatment and Research Communications. 15. 17–20. 11 indexed citations

14.

Hallowell, Robert W., et al.. (2016). Intravenous Immunoglobulin as Potential Adjunct Therapy for Interstitial Lung Disease. Annals of the American Thoracic Society. 13(10). 1682–1688. 29 indexed citations

15.

Hallowell, Robert W. & Sonye K. Danoff. (2014). Interstitial lung disease associated with the idiopathic inflammatory myopathies and the antisynthetase syndrome. Current Opinion in Rheumatology. 26(6). 684–689. 38 indexed citations

16.

Hamblin, Mark J., Michael Eberlein, Katharine E. Black, et al.. (2014). Lovastatin Inhibits Low Molecular Weight Hyaluronan Induced Chemokine Expression via LFA-1 and Decreases Bleomycin-Induced Pulmonary Fibrosis. International Journal of Biomedical Science. 10(3). 146–157. 8 indexed citations

17.

Black, Katharine E., Samuel L. Collins, Robert S. Hagan, et al.. (2013). Hyaluronan fragments induce IFNβ via a novel TLR4-TRIF-TBK1-IRF3-dependent pathway. Journal of Inflammation. 10(1). 23–23. 49 indexed citations

18.

Hallowell, Robert W., Robert M. Reed, Mostafa Fraig, Maureen R. Horton, & Reda E. Girgis. (2012). Severe Pulmonary Hypertension in Idiopathic Nonspecific Interstitial Pneumonia. Pulmonary Circulation. 2(1). 101–106. 13 indexed citations

19.

Collins, Samuel L., Yee Chan‐Li, Robert W. Hallowell, Jonathan D. Powell, & Maureen R. Horton. (2012). Pulmonary Vaccination as a Novel Treatment for Lung Fibrosis. PLoS ONE. 7(2). e31299–e31299. 21 indexed citations

20.

Horton, Maureen R. & Robert W. Hallowell. (2012). Revisiting thalidomide: fighting with caution against idiopathicpulmonary fibrosis. Drugs of today. 48(10). 661–661. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact